PHILIP GAUSLIN: Open Payments
NPI 1962427732 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 56 payments from 14 companies in 2025. Trend: 2023 $599 · 2024 $1,134 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $214 |
| Novartis Pharmaceuticals Corporation | 12 | $156 |
| Lilly USA, LLC | 9 | $142 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Lundbeck LLC | 4 | $80 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Exact Sciences Corporation | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
Products named: LEQVIO, Ozempic, MOUNJARO, AIRSUPRA, Wegovy, REXULTI, SHINGRIX, Rybelsus.
Industry payments across TN — which companies pay providers there.
